These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15174297)

  • 21. Probing the molecular mechanism of interaction between 4-n-butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the muscarinic M(1) receptor: direct pharmacological evidence that AC-42 is an allosteric agonist.
    Langmead CJ; Fry VA; Forbes IT; Branch CL; Christopoulos A; Wood MD; Herdon HJ
    Mol Pharmacol; 2006 Jan; 69(1):236-46. PubMed ID: 16207821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function studies of allosteric agonism at M2 muscarinic acetylcholine receptors.
    May LT; Avlani VA; Langmead CJ; Herdon HJ; Wood MD; Sexton PM; Christopoulos A
    Mol Pharmacol; 2007 Aug; 72(2):463-76. PubMed ID: 17525129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allosteric modulators of metabotropic glutamate receptors: lessons learnt from mGlu1, mGlu2 and mGlu5 potentiators and antagonists.
    Johnson MP; Nisenbaum ES; Large TH; Emkey R; Baez M; Kingston AE
    Biochem Soc Trans; 2004 Nov; 32(Pt 5):881-7. PubMed ID: 15494040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical studies of opioids and opioid antagonists on gastrointestinal function.
    Greenwood-Van Meerveld B; Gardner CJ; Little PJ; Hicks GA; Dehaven-Hudkins DL
    Neurogastroenterol Motil; 2004 Oct; 16 Suppl 2():46-53. PubMed ID: 15357851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-apoptotic effects of allopregnanolone on P19 neurons.
    Xilouri M; Papazafiri P
    Eur J Neurosci; 2006 Jan; 23(1):43-54. PubMed ID: 16420414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms and binding site locations for noncompetitive antagonists of nicotinic acetylcholine receptors.
    Arias HR; Bhumireddy P; Bouzat C
    Int J Biochem Cell Biol; 2006; 38(8):1254-76. PubMed ID: 16520081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure and trafficking of NMDA and GABAA receptors.
    Stephenson FA
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):877-81. PubMed ID: 17052219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxytocin receptors: ligand binding, signalling and cholesterol dependence.
    Gimpl G; Reitz J; Brauer S; Trossen C
    Prog Brain Res; 2008; 170():193-204. PubMed ID: 18655883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term synaptic plasticity in the spinal dorsal horn and its modulation by electroacupuncture in rats with neuropathic pain.
    Xing GG; Liu FY; Qu XX; Han JS; Wan Y
    Exp Neurol; 2007 Dec; 208(2):323-32. PubMed ID: 17936754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
    Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
    J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of orthosteric ligands to the allosteric site of the M(2) muscarinic cholinergic receptor.
    Redka DS; Pisterzi LF; Wells JW
    Mol Pharmacol; 2008 Sep; 74(3):834-43. PubMed ID: 18552124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrative action of receptor mosaics: relevance of receptor topology and allosteric modulators.
    Francesco AL; Diego G; Susanna G; Giuseppina L; Amina WS; Sergi F; Rafael F; Kjell F
    J Recept Signal Transduct Res; 2008; 28(6):543-65. PubMed ID: 19096975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of 5-HT 1B receptors facilitates contextual aversive learning in mice by disinhibition of cholinergic and glutamatergic neurotransmission.
    Eriksson TM; Madjid N; Elvander-Tottie E; Stiedl O; Svenningsson P; Ogren SO
    Neuropharmacology; 2008 Jun; 54(7):1041-50. PubMed ID: 18394658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional and ultrastructural neuroanatomy of interactive intratectal/tectonigral mesencephalic opioid inhibitory links and nigrotectal GABAergic pathways: involvement of GABAA and mu1-opioid receptors in the modulation of panic-like reactions elicited by electrical stimulation of the dorsal midbrain.
    Ribeiro SJ; Ciscato JG; de Oliveira R; de Oliveira RC; D'Angelo-Dias R; Carvalho AD; Felippotti TT; Rebouças EC; Castellan-Baldan L; Hoffmann A; Corrêa SA; Moreira JE; Coimbra NC
    J Chem Neuroanat; 2005 Dec; 30(4):184-200. PubMed ID: 16140499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of agonists and antagonists of NMDA and ACh receptors on plasticity of bat auditory system elicited by fear conditioning.
    Ji W; Suga N; Gao E
    J Neurophysiol; 2005 Aug; 94(2):1199-211. PubMed ID: 16061490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation mechanism of the heterodimeric GABA(B) receptor.
    Pin JP; Kniazeff J; Binet V; Liu J; Maurel D; Galvez T; Duthey B; Havlickova M; Blahos J; Prézeau L; Rondard P
    Biochem Pharmacol; 2004 Oct; 68(8):1565-72. PubMed ID: 15451400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment.
    Gjoni T; Urwyler S
    Eur J Pharmacol; 2009 Jan; 603(1-3):37-41. PubMed ID: 19109945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.